(NASDAQ: OPT) Opthea's forecast annual revenue growth rate of 1,018.94% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 33.54%, and it is also forecast to beat the US market's average forecast revenue growth rate of 8.75%.
Opthea's revenue in 2024 is $261,859.On average, 3 Wall Street analysts forecast OPT's revenue for 2025 to be $232,482,422, with the lowest OPT revenue forecast at $109,146,677, and the highest OPT revenue forecast at $327,440,031. On average, 3 Wall Street analysts forecast OPT's revenue for 2026 to be $110,380,034,551, with the lowest OPT revenue forecast at $27,286,669,275, and the highest OPT revenue forecast at $268,871,924,368.
In 2027, OPT is forecast to generate $436,379,329,714 in revenue, with the lowest revenue forecast at $81,641,714,471 and the highest revenue forecast at $1,047,502,489,464.